Janssen/Johnson & Johnson COVID-19 Vaccine Expiration Extension On July 29, 2021, the U.S. Food & Drug Administration (FDA) authorized an extension of the shelf life for the Janssen/Johnson & Johnson (J&J) single-shot COVID-19 vaccine by 45 days, from 4.5 months to 6 months. The decision is based on data from ongoing stability assessment studies, which have
Important Information regarding Janssen/Johnson & Johnson (J&J) COVID-19 Vaccine On July 13, 2021, the U.S. Food and Drug Administration (FDA) announced revisions to the Emergency Use Authorization (EUA) fact sheets for the Janssen/Johnson & Johnson (J&J) COVID-19 vaccine to include information regarding an observed increased risk of Guillain-Barre Syndrome (GBS) after administration of the vaccine.
Dear COVID-19 Vaccination Program Provider: This message is being sent to all COVID-19 Vaccination Program enrolled providers in an effort to increase vaccinated individuals’ ability to obtain an Excelsior Pass. If you have not yet administered COVID-19 vaccine, you may disregard this message. Excelsior Pass mobile application is New York State’s voluntary and secure way
